HomeSANA • NASDAQ
Sana Biotechnology Inc
add
$2.66
9.08%
Pre-market:(4.71%)+0.13
$2.78
Closed: Mar 14, 8:01:05 AM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 61.53M | 1.26% |
Net income | -59.92M | -6,189.84% |
Net profit margin | — | — |
Earnings per share | -0.27 | 34.15% |
EBITDA | -57.47M | -2.15% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 199.01M | -25.90% |
Total assets | 559.39M | -11.41% |
Total liabilities | 266.91M | 0.50% |
Total equity | 292.48M | — |
Shares outstanding | 223.27M | — |
Price to book | 2.23 | — |
Return on assets | -26.11% | — |
Return on capital | -37.21% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -59.92M | -6,189.84% |
Cash from operations | -51.82M | 18.46% |
Cash from investing | 41.78M | -18.64% |
Cash from financing | 2.08M | 1,013.37% |
Net change in cash | -7.96M | 33.73% |
Free cash flow | -31.34M | 55.87% |
Previous close
$2.92
Day range
$2.61 - $3.00
Year range
$1.52 - $10.50
Market cap
592.78M USD
Avg Volume
2.90M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
CEO
Founded
2018
Headquarters
Website
Employees
328
